GlassScriptPhysician profile
Daniel Nelson Fong
NPI 1124224431
$1,933.11
in general payments reported to CMS, 2019-2025
23 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $69.27 · 2021: $361 · 2022: $440 · 2023: $358 · 2024: $228 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $741.63 | 2019-2023 | |
| Organon LLC | $396.90 | 2021-2025 | Nexplanon, Nuvaring |
| Hologic Sales and Service, LLC | $133.80 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Amgen INC. | $116.30 | 2019-2023 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $77.58 | 2023-2025 | |
| Intuitive Surgical, INC. | $73.68 | 2023 | Da Vinci Surgical System |
| Avion Pharmaceuticals | $55.70 | 2019-2021 | |
| Astellas Pharma US INC | $54.05 | 2020-2023 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $39.95 | 2021-2025 | |
| Roche Diagnostics Corporation | $38.71 | 2019 | |
| Conmed Corporation | $27.08 | 2025 | Airseal |
| Sumitomo Pharma America, INC. | $22.33 | 2024 | Myfembree |
| Coopersurgical, INC. | $20.20 | 2025 | Paragard T 380a |
| Baudax Bio INC. | $16.39 | 2022 | |
| Shield Therapeutics INC | $16.25 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $13.78 | 2023 | |
| Mylan Pharmaceuticals INC. | $13.64 | 2021 | |
| Allergan, INC. | $13.63 | 2020 | |
| Therapeuticsmd, INC. | $13.35 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.99 | 2019 | |
| Acessa Health INC. | $12.54 | 2019 | |
| Merck Sharp & Dohme LLC | $11.32 | 2021 | |
| Mallinckrodt Hospital Products INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.